Abstract: The present invention relates to novel macrocyclic compounds of Formula I and their use as novel therapeutic agents for example as novel compounds used in methods of preventing and/or treating a disease, condition or state in a subject associated with dysregulation of protease activity and/or dysregulation of proteosome activity
Type:
Application
Filed:
November 15, 2013
Publication date:
October 22, 2015
Inventors:
Andrew David Abell, Krystle Chua, Markus Pietsch